{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:39:09Z","timestamp":1789000749414,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00702-019-01980-7","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T07:11:18Z","timestamp":1549437078000},"page":"905-912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Management of delirium in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-6987","authenticated-orcid":false,"given":"Georg","family":"Ebersbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Wang","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Koschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Lorenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"1980_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1017\/S1478951514001059","volume":"13","author":"S Boettger","year":"2015","unstructured":"Boettger S, Jenewein J, Breitbart W (2015) Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: a comparison of efficacy, safety, and side effects. Palliat Support Care 13:1079\u20131085","journal-title":"Palliat Support Care"},{"key":"1980_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0885-3924(96)00316-8","volume":"13","author":"W Breitbart","year":"1997","unstructured":"Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S (1997) The Memorial Delirium Assessment Scale. J Pain Symptom Manag 13:128\u2013137","journal-title":"J Pain Symptom Manag"},{"key":"1980_CR3","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1007\/s12035-015-9350-8","volume":"53","author":"S Chen","year":"2016","unstructured":"Chen S, Shi L, Liang F, Xu L, Desislava D, Wu Q, Zhang J (2016) Exogenous melatonin for delirium prevention: a meta-analysis of randomized controlled trials. Mol Neurobiol 53:4046\u20134053","journal-title":"Mol Neurobiol"},{"key":"1980_CR4","first-page":"753","volume":"167","author":"MG Cole","year":"2002","unstructured":"Cole MG, McCusker J, Bellavance F, Primeau FJ, Bailey RF, Bonnycastle MJ, Laplante J (2002) Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial. CMAJ 167:753\u2013759","journal-title":"CMAJ"},{"key":"1980_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/mds.870050404","volume":"5","author":"SA Factor","year":"1990","unstructured":"Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ (1990) Sleep disorders and sleep effect in Parkinson\u2019s disease. Mov Disord 5:280\u2013285","journal-title":"Mov Disord"},{"key":"1980_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/ageing\/afy112","volume":"47","author":"AR Feast","year":"2018","unstructured":"Feast AR, White N, Lord K, Kupeli N, Vickerstaff V, Sampson EL (2018) Pain and delirium in people with dementia in the acute general hospital setting. Age Ageing 47:841\u2013846","journal-title":"Age Ageing"},{"key":"1980_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00134-009-1397-4","volume":"35","author":"MI Figueroa-Ramos","year":"2009","unstructured":"Figueroa-Ramos MI, Arroyo-Novoa CM, Lee KA, Padilla G, Puntillo KA (2009) Sleep and delirium in ICU patients: a review of mechanisms and manifestations. Intensive Care Med 35:781\u2013795","journal-title":"Intensive Care Med"},{"key":"1980_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/gerona\/glq136","volume":"65","author":"JH Flaherty","year":"2010","unstructured":"Flaherty JH, Steele DK, Chibnall JT, Vasudevan VN, Bassil N, Vegi S (2010) An ACE unit with a delirium room may improve function and equalize length of stay among older delirious medical inpatients. J Gerontol A Biol Sci Med Sci 65:1387\u20131392","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1980_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.euroneuro.2006.08.007","volume":"17","author":"H Frieling","year":"2007","unstructured":"Frieling H, Hillemacher T, Ziegenbein M, Neundorfer B, Bleich S (2007) Treating dopamimetic psychosis in Parkinson\u2019s disease: structured review and meta-analysis. Eur Neuropsychopharmacol 17:165\u2013171","journal-title":"Eur Neuropsychopharmacol"},{"key":"1980_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"1980_CR11","first-page":"3","volume":"59","author":"G Honigfeld","year":"1998","unstructured":"Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J (1998) Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry 59(Suppl 3):3\u20137","journal-title":"J Clin Psychiatry"},{"key":"1980_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/07853890009011770","volume":"32","author":"SK Inouye","year":"2000","unstructured":"Inouye SK (2000) Prevention of delirium in hospitalized older patients: risk factors and targeted intervention strategies. Ann Med 32:257\u2013263","journal-title":"Ann Med"},{"key":"1980_CR13","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/j.1532-5415.2006.00869.x","volume":"54","author":"SK Inouye","year":"2006","unstructured":"Inouye SK, Baker DI, Fugal P, Bradley EH, Project HD (2006) Dissemination of the hospital elder life program: implementation, adaptation, and successes. J Am Geriatr Soc 54:1492\u20131499","journal-title":"J Am Geriatr Soc"},{"key":"1980_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/M13-1927","volume":"160","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Kosar CM, Tommet D, Schmitt EM, Puelle MR, Saczynski JS, Marcantonio ER, Jones RN (2014a) The CAM-S: development and validation of a new scoring system for delirium severity in 2 cohorts. Ann Intern Med 160:526\u2013533","journal-title":"Ann Intern Med"},{"key":"1980_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","volume":"383","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS (2014b) Delirium in elderly people. Lancet 383:911\u2013922","journal-title":"Lancet"},{"key":"1980_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0033-3182(10)70723-4","volume":"51","author":"KA Larsen","year":"2010","unstructured":"Larsen KA, Kelly SE, Stern TA, Bode RH Jr, Price LL, Hunter DJ, Gulczynski D, Bierbaum BE, Sweeney GA, Hoikala KA, Cotter JJ, Potter AW (2010) Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics 51:409\u2013418","journal-title":"Psychosomatics"},{"key":"1980_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.09.025","author":"RA Lawson","year":"2018","unstructured":"Lawson RA, McDonald C, Burn DJ (2018) Defining delirium in idiopathic Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2018.09.025","journal-title":"Parkinsonism Relat Disord"},{"key":"1980_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archinte.1992.00400140082019","volume":"152","author":"SE Levkoff","year":"1992","unstructured":"Levkoff SE, Evans DA, Liptzin B, Cleary PD, Lipsitz LA, Wetle TT, Reilly CH, Pilgrim DM, Schor J, Rowe J (1992) Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 152:334\u2013340","journal-title":"Arch Intern Med"},{"key":"1980_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005594.pub2","author":"E Lonergan","year":"2007","unstructured":"Lonergan E, Britton AM, Luxenberg J, Wyller T (2007) Antipsychotics for delirium. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005594.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1980_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/jnnp-2014-307822","volume":"86","author":"M Lubomski","year":"2015","unstructured":"Lubomski M, Rushworth RL, Tisch S (2015) Hospitalisation and comorbidities in Parkinson\u2019s disease: a large Australian retrospective study. J Neurol Neurosurg Psychiatry 86:324\u2013330","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1980_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"1980_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/jgs.14076","volume":"64","author":"KJ Neufeld","year":"2016","unstructured":"Neufeld KJ, Yue J, Robinson TN, Inouye SK, Needham DM (2016) Antipsychotic medication for prevention and treatment of delirium in hospitalized adults: a systematic review and meta-analysis. J Am Geriatr Soc 64:705\u2013714","journal-title":"J Am Geriatr Soc"},{"key":"1980_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3928\/00989134-20070201-04","volume":"33","author":"M Park","year":"2007","unstructured":"Park M, Tang JH (2007) Changing the practice of physical restraint use in acute care. J Gerontol Nurs 33:9\u201316","journal-title":"J Gerontol Nurs"},{"key":"1980_CR24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM199903113401003","volume":"340","author":"Parkinson Study Group","year":"1999","unstructured":"Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease. N Engl J Med 340:757\u2013763","journal-title":"N Engl J Med"},{"key":"1980_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/gerona\/61.2.176","volume":"61","author":"KH Pitkala","year":"2006","unstructured":"Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS (2006) Multicomponent geriatric intervention for elderly inpatients with delirium: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci 61:176\u2013181","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1980_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","volume":"75","author":"P Pollak","year":"2004","unstructured":"Pollak P, Tison F, Rascol O, Destee A, Pere JJ, Senard JM, Durif F, Bourdeix I (2004) Clozapine in drug induced psychosis in Parkinson\u2019s disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatry 75:689\u2013695","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1980_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168:508\u2013513","journal-title":"Arch Intern Med"},{"key":"1980_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1112923","volume":"367","author":"JS Saczynski","year":"2012","unstructured":"Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN (2012) Cognitive trajectories after postoperative delirium. N Engl J Med 367:30\u201339","journal-title":"N Engl J Med"},{"key":"1980_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0269216310371556","volume":"24","author":"MB Sands","year":"2010","unstructured":"Sands MB, Dantoc BP, Hartshorn A, Ryan CJ, Lujic S (2010) Single question in delirium (SQiD): testing its efficacy against psychiatrist interview, the Confusion Assessment Method and the Memorial Delirium Assessment Scale. Palliat Med 24:561\u2013565","journal-title":"Palliat Med"},{"key":"1980_CR30","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/S0140-6736(09)60658-9","volume":"373","author":"WD Schweickert","year":"2009","unstructured":"Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L et al (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373:1874\u20131882","journal-title":"Lancet"},{"issue":"Suppl 3","key":"1980_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mds.23884","volume":"26","author":"K Seppi","year":"2011","unstructured":"Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C (2011) The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease. Mov Disord 26(Suppl 3):42\u201380","journal-title":"Mov Disord"},{"key":"1980_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.parkreldis.2005.05.002","volume":"11","author":"M Serrano-Duenas","year":"2005","unstructured":"Serrano-Duenas M, Bleda MJ (2005) Delirium in Parkinson\u2019s disease patients. A five-year follow-up study. Parkinsonism Relat Disord 11:387\u2013392","journal-title":"Parkinsonism Relat Disord"},{"key":"1980_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/jnp.13.2.229","volume":"13","author":"PT Trzepacz","year":"2001","unstructured":"Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N (2001) Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 13:229\u2013242","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1980_CR34","doi-asserted-by":"publisher","first-page":"e94944","DOI":"10.1371\/journal.pone.0094944","volume":"9","author":"A Umemura","year":"2014","unstructured":"Umemura A, Oeda T, Tomita S, Hayashi R, Kohsaka M, Park K, Sugiyama H, Sawada H (2014) Delirium and high fever are associated with subacute motor deterioration in Parkinson disease: a nested case-control study. PLoS One 9:e94944","journal-title":"PLoS One"},{"key":"1980_CR35","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(10)61855-7","volume":"376","author":"MM Eijk van","year":"2010","unstructured":"van Eijk MM, Roes KC, Honing ML, Kuiper MA, Karakus A, van der Jagt M, Spronk PE, van Gool WA, van der Mast RC, Kesecioglu J, Slooter AJ (2010) Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 376:1829\u20131837","journal-title":"Lancet"},{"key":"1980_CR36","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00415-015-7760-1","volume":"262","author":"ER Vardy","year":"2015","unstructured":"Vardy ER, Teodorczuk A, Yarnall AJ (2015) Review of delirium in patients with Parkinson\u2019s disease. J Neurol 262:2401\u20132410","journal-title":"J Neurol"},{"key":"1980_CR37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1017\/S1041610206003310","volume":"18","author":"S Vida","year":"2006","unstructured":"Vida S, Galbaud du Fort G, Kakuma R, Arsenault L, Platt RW, Wolfson CM (2006) An 18-month prospective cohort study of functional outcome of delirium in elderly patients: activities of daily living. Int Psychogeriatr 18:681\u2013700","journal-title":"Int Psychogeriatr"},{"key":"1980_CR38","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/1060028017703992","volume":"51","author":"KJ Wilby","year":"2017","unstructured":"Wilby KJ, Johnson EG, Johnson HE, Ensom MHH (2017) Evidence-based review of pharmacotherapy used for Parkinson\u2019s disease psychosis. Ann Pharmacother 51:682\u2013695","journal-title":"Ann Pharmacother"},{"key":"1980_CR39","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0b013e31824d5894","volume":"78","author":"RS Wilson","year":"2012","unstructured":"Wilson RS, Hebert LE, Scherr PA, Dong X, Leurgens SE, Evans DA (2012) Cognitive decline after hospitalization in a community population of older persons. Neurology 78:950\u2013956","journal-title":"Neurology"},{"key":"1980_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jama.2010.1013","volume":"304","author":"J Witlox","year":"2010","unstructured":"Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304:443\u2013451","journal-title":"JAMA"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-019-01980-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-01980-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-01980-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T19:19:43Z","timestamp":1580930383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-019-01980-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1980"],"URL":"https:\/\/doi.org\/10.1007\/s00702-019-01980-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Prof. Georg Ebersbach, MD: Consultancy fees: AOK Nordost. Fees for advisory board participation: AbbVie Pharma, Gr\u00fcnenthal Pharma, Neuroderm Inc., Stada Pharma, Neurocrine Inc. Lecture fees: AbbVie Pharma, BIAL Pharma, Britannia Pharma, Desitin Pharma, Licher GmbH, UCB Pharma, Zambon Pharma, Royalties: Kohlhammer Verlag, Thieme Verlag. Dr. Chi Wang Ip, MD Fees for advisory board participation Merz Pharmaceuticals, LLC, Ipsen Pharm and TEVA; Funding for travel: Desitin Pharma, Ipsen Pharm, Merz Pharmaceuticals, LLC, Allergan, Inc.; Lecture fees: Merz, Ipsen Pharm, TEVA, Allergan, Inc. Prof. Stephan Klebe, MD: Lecture fees: Allergan Pharma, Merz Pharmaceuticals ; Royalties: Thieme Verlag. Prof. Christian Winkler, MD PhD: Fees for adivsory board participation: AbbVie Pharma, BIAL Pharma, UCB Pharma. Lecture fees: AbbVie Pharma, BIAL Pharma, Licher MT, UCB Pharma. Prof. Stefan Lorenzl, MD: Lecture fees: AbbVie Pharma, UCB Pharma, Desitin Pharma, Royalties: Kohlhammer Verlag, Thieme Verlag. Dr. Christoph Schrader: Consultancy fees from Abbvie Deutschland, Fees for advisory board participation: AbbVie Pharma, Lecture fees: Abbvie Deutschland, Desitin Pharma, Merz Pharmaceuticals ; Royalties: Elsevier. Christiana Franke, and MD declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}